Skip to main content

Cancer drug listing

Find detailed information for nearly 200 cancer drugs, including brand and generic names for each drug, what it is intended to treat, how it is administered, and possible side effects.

To find out if a Food and Drug Administration-approved drug is in short supply, visit the FDA website.

Showing results for:

Busulfan

Drug name(s)

Busulfex® Myleran® Busulfan

Approved for

  • Leukemia
  • Chronic Myeloid Leukemia (CML)

Dexamethasone

Drug name(s)

Prednisone Decadron® Medrol® Methylprednisolone Dexamethasone

Approved for

  • Other Blood Cancers

Gemtuzumab ozogamicin

Drug name(s)

Mylotarg® Gemtuzumab ozogamicin

Approved for

  • Leukemia
  • Acute Myeloid Leukemia (AML)

Mechlorethamine

Drug name(s)

Mustargen® nitrogen mustard Mechlorethamine

Approved for

  • Chronic Lymphocytic Leukemia (CLL/SLL)
  • Chronic Myeloid Leukemia (CML)
  • Lymphoma
  • Hodgkin Lymphoma (HL)
  • Polycythemia Vera

Mechlorethamine gel

Drug name(s)

Valchlor® Mechlorethamine gel

Approved for

  • Lymphoma
  • Adult T-cell Leukemia/Lymphoma
  • Other Blood Cancers

Melphalan

Drug name(s)

Alkeran® Melphalan

Approved for

  • Myeloma

Melphalan hydrochloride

Drug name(s)

Evomela™ Melphalan hydrochloride

Approved for

  • Myeloma

Mercaptopurine

Drug name(s)

Purinethol® 6-MP Purixan® Mercaptopurine

Approved for

  • Leukemia
  • Acute Lymphoblastic Leukemia (ALL)

Methotrexate

Drug name(s)

Rheumatrex® Trexall® Methotrexate

Approved for

  • Leukemia
  • Acute Lymphoblastic Leukemia (ALL)
  • Non-Hodgkin Lymphoma (NHL)
  • Other Blood Cancers

Midostaurin

Drug name(s)

Rydapt® Midostaurin

Approved for

  • Leukemia
  • Acute Myeloid Leukemia (AML)
  • Other Blood Cancers

Mitomycin

Drug name(s)

Mutamycin® Mitomycin

Approved for

  • Other Blood Cancers

Mitoxantrone

Drug name(s)

Novantrone® Mitoxantrone

Approved for

  • Leukemia
  • Other Blood Cancers

Mogamulizumab

Drug name(s)

Poteligeo® Mogamulizumab

Approved for

  • Other Blood Cancers

Momelotinib

Drug name(s)

Momelotinib Ojjaara

Approved for

  • Essential Thrombocythemia
  • Primary Myelofibrosis
  • Polycythemia Vera

Mosunetuzumab-axgb

Drug name(s)

Mosunetuzumab-axgb Lunsumio® Lunsumio VELO™

Approved for

  • Lymphoma
  • Non-Hodgkin Lymphoma (NHL)
  • Follicular Lymphoma (FL) 

Plerixafor

Drug name(s)

Mozobil® Plerixafor

Approved for

  • Lymphoma
  • Non-Hodgkin Lymphoma (NHL)
  • Myeloma

Procarbazine

Drug name(s)

Matulane® Procarbazine

Approved for

  • Lymphoma
  • Hodgkin Lymphoma (HL)

Tafasitamab-cxix

Drug name(s)

Monjuvi® Tafasitamab-cxix

Approved for

  • Lymphoma
  • Diffuse Large B-cell Lymphoma (DLBCL) 

The Leukemia & Lymphoma Society (LLS) is now Blood Cancer United. Learn more.